Cláudia Marchetti

5.4k total citations
178 papers, 3.3k citations indexed

About

Cláudia Marchetti is a scholar working on Reproductive Medicine, Oncology and Obstetrics and Gynecology. According to data from OpenAlex, Cláudia Marchetti has authored 178 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Reproductive Medicine, 67 papers in Oncology and 47 papers in Obstetrics and Gynecology. Recurrent topics in Cláudia Marchetti's work include Ovarian cancer diagnosis and treatment (110 papers), PARP inhibition in cancer therapy (44 papers) and Endometrial and Cervical Cancer Treatments (38 papers). Cláudia Marchetti is often cited by papers focused on Ovarian cancer diagnosis and treatment (110 papers), PARP inhibition in cancer therapy (44 papers) and Endometrial and Cervical Cancer Treatments (38 papers). Cláudia Marchetti collaborates with scholars based in Italy, Pakistan and France. Cláudia Marchetti's co-authors include Pierluigi Benedetti Panici, Ludovico Muzii, Innocenza Palaia, Francesca De Felice, Giorgia Perniola, Angela Musella, Violante Di Donato, Vincenzo Tombolini, Giovanni Scambia and Anna Fagotti and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and American Journal of Obstetrics and Gynecology.

In The Last Decade

Cláudia Marchetti

168 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cláudia Marchetti Italy	33	1.5k	968	885	719	649	178	3.3k
Bhavana Pothuri United States	30	1.1k 0.7×	1.2k 1.3×	683 0.8×	1.1k 1.5×	686 1.1×	203	3.4k
Atsuhiko Sakamoto Japan	28	929 0.6×	1.0k 1.0×	849 1.0×	618 0.9×	648 1.0×	126	3.5k
Innocenza Palaia Italy	36	1.7k 1.1×	966 1.0×	1.4k 1.6×	406 0.6×	885 1.4×	187	3.6k
Christine Walsh United States	30	1.0k 0.7×	874 0.9×	687 0.8×	845 1.2×	282 0.4×	93	2.6k
Stefania Cosio Italy	36	1.7k 1.1×	893 0.9×	1.5k 1.7×	729 1.0×	757 1.2×	118	3.4k
Margaret M. Steinhoff United States	34	1.5k 1.0×	1.0k 1.1×	1.2k 1.3×	874 1.2×	959 1.5×	77	3.9k
Alexander Burges Germany	35	1.9k 1.3×	1.3k 1.3×	887 1.0×	809 1.1×	1.4k 2.2×	171	4.1k
Violante Di Donato Italy	37	1.5k 1.0×	813 0.8×	1.6k 1.8×	396 0.6×	949 1.5×	214	3.7k
Patricia L. Judson United States	25	1.4k 0.9×	1.2k 1.2×	904 1.0×	598 0.8×	850 1.3×	68	3.4k
G. Larry Maxwell United States	37	2.3k 1.5×	977 1.0×	1.8k 2.1×	1.4k 2.0×	1.1k 1.7×	168	4.9k

Countries citing papers authored by Cláudia Marchetti

Since Specialization

Citations

This map shows the geographic impact of Cláudia Marchetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cláudia Marchetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cláudia Marchetti more than expected).

Fields of papers citing papers by Cláudia Marchetti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cláudia Marchetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cláudia Marchetti. The network helps show where Cláudia Marchetti may publish in the future.

Co-authorship network of co-authors of Cláudia Marchetti

This figure shows the co-authorship network connecting the top 25 collaborators of Cláudia Marchetti. A scholar is included among the top collaborators of Cláudia Marchetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cláudia Marchetti. Cláudia Marchetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tortorella, Lucia, Serena Cappuccio, Diana Giannarelli, et al.. (2024). Distribution and prognostic role of BRCA status in elderly ovarian cancer patients. Gynecologic Oncology. 182. 57–62. 1 indexed citations

Peters, Inge, Cláudia Marchetti, Giovanni Scambia, & Anna Fagotti. (2024). New windows of surgical opportunity for gynecological cancers in the era of targeted therapies. International Journal of Gynecological Cancer. 34(3). 352–362. 4 indexed citations

You, Benoît, Anna Fagotti, Olivier Colomban, et al.. (2024). Consistent data about the predictive factors of the success of interval debulking surgery (CC0-IDS) in patients with advanced ovarian cancers in two large independent datasets.. Journal of Clinical Oncology. 42(16_suppl). 5560–5560.

Bruno, Matteo, Serena Maria Boccia, Domenica Lorusso, et al.. (2024). Effects of niraparib dose reduction on short-term outcomes in ovarian cancer patients. International Journal of Gynecological Cancer. 34(10). 1588–1595. 2 indexed citations

Nero, Camilla, Maria De Bonis, Cláudia Marchetti, et al.. (2023). #759 Comprehensive cancer genomic profiling in matched primary tumor and brain metastasis samples of ovarian cancer patients: a single-institution case series. A25–A26. 1 indexed citations

Musacchio, Lucia, Serena Maria Boccia, Cláudia Marchetti, et al.. (2023). Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors. International Journal of Gynecological Cancer. 33(6). 922–928. 1 indexed citations

Marchetti, Cláudia, Diana Giannarelli, Giuseppe Vizzielli, et al.. (2023). Quality of life in patients with advanced ovarian cancer after primary debulking surgery versus neoadjuvant chemotherapy: Results from the randomised SCORPION trial (NCT01461850). BJOG An International Journal of Obstetrics & Gynaecology. 130(13). 1579–1588. 7 indexed citations

Cappuccio, Serena, Cláudia Marchetti, Barbara Costantini, et al.. (2023). Low-grade versus high-grade serous ovarian cancer: comparison of surgical outcomes after secondary cytoreductive surgery. International Journal of Gynecological Cancer. 34(2). 293–299. 2 indexed citations

Marchetti, Cláudia, Giovanni Scambia, Diana Giannarelli, et al.. (2022). 2022-RA-972-ESGO Quality of life in patients with advanced ovarian cancer after primary debulking surgery versus neoadjuvant chemotherapy: results from the randomized SCORPION Trial. International Journal of Gynecological Cancer. 32. A395–A396. 2 indexed citations

10.

Palluzzi, Eleonora, Cláudia Marchetti, Serena Cappuccio, et al.. (2022). Management of oligometastatic ovarian cancer recurrence during PARP inhibitor maintenance. International Journal of Gynecological Cancer. 32(9). 1164–1170. 19 indexed citations

11.

Conte, Carmine, Andrea Rosati, Cláudia Marchetti, et al.. (2022). Nomogram to predict feasibility of minimally invasive interval debulking surgery in advanced ovarian cancer. International Journal of Gynecological Cancer. 32(4). 532–539. 2 indexed citations

12.

Bizzarri, Nicolò, Marco D’Indinosante, Cláudia Marchetti, et al.. (2022). The prognostic role of systemic inflammatory markers in apparent early-stage ovarian cancer. International Journal of Clinical Oncology. 28(2). 314–320. 20 indexed citations

13.

Vertechy, Laura, Serena Maria Boccia, Giacomo Avesani, et al.. (2022). Trabectedin plus pegylated liposomal doxorubicin in patients with disease progression after PARP inhibitor maintenance: a real-life case–control study. International Journal of Gynecological Cancer. 33(2). 243–249. 5 indexed citations

14.

Paolis, Elisa De, Cláudia Marchetti, Antonella Pietragalla, et al.. (2022). BRCA testing on buccal swab to improve access to healthcare and cancer prevention: a performance evaluation. International Journal of Gynecological Cancer. 32(11). 1419–1426. 1 indexed citations

15.

Marchetti, Cláudia, Martina Arcieri, Laura Vertechy, et al.. (2022). Risk reducing surgery with peritoneal staging in BRCA1-2 mutation carriers. A prospective study. European Journal of Surgical Oncology. 48(12). 2539–2544. 5 indexed citations

16.

Marchetti, Cláudia, Riccardo Tudisco, Vanda Salutari, et al.. (2021). Neoadjuvant chemoteraphy in unresectable ovarian cancer with olaparib and weekly carboplatin plus paclitaxel: a phase II, open label multicenter study (NUVOLA trial). International Journal of Gynecological Cancer. 31(8). 1175–1178. 5 indexed citations

17.

Pietragalla, Antonella, Martina Arcieri, Cláudia Marchetti, Giovanni Scambia, & Anna Fagotti. (2020). Ovarian cancer predisposition beyond BRCA1 and BRCA2 genes. International Journal of Gynecological Cancer. 30(11). 1803–1810. 40 indexed citations

18.

Marchetti, Cláudia, Emanuele Rocco Villani, Domenico Fusco, et al.. (2019). ToleRability of BevacizUmab in elderly Ovarian cancer patients (TURBO study): a case-control study of a real-life experience. Journal of Gynecologic Oncology. 31(1). e6–e6. 8 indexed citations

19.

Musella, Angela, Erlisa Bardhi, Cláudia Marchetti, et al.. (2018). Rucaparib: An emerging parp inhibitor for treatment of recurrent ovarian cancer. Cancer Treatment Reviews. 66. 7–14. 50 indexed citations

20.

Marchetti, Cláudia, et al.. (2013). An Unexpected Complete Remission of Advanced Intestinal-Type Vulvar Adenocarcinoma after Neoadjuvant Chemotherapy: A Case Report and a Literature Review. Case Reports in Obstetrics and Gynecology. 2013. 1–5. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact